Premium
BRAF mutation in follicular variant of papillary thyroid carcinoma is associated with unfavourable clinicopathological characteristics and malignant features on ultrasonography
Author(s) -
Chai Young Jun,
Kim Sujin,
Kim Soo Chin,
Koo Do Hoon,
Min Hye Sook,
Lee Kyu Eun,
Kim Jihoon,
Youn YeoKyu
Publication year - 2014
Publication title -
clinical endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.055
H-Index - 147
eISSN - 1365-2265
pISSN - 0300-0664
DOI - 10.1111/cen.12433
Subject(s) - medicine , thyroid carcinoma , mutation , malignancy , sanger sequencing , oncology , carcinoma , stage (stratigraphy) , thyroid , gastroenterology , pathology , biology , gene , genetics , paleontology
Summary Objective Follicular variant of papillary thyroid carcinoma ( FVPTC ) is a common variant of papillary thyroid carcinoma ( PTC ), but the association between BRAF mutation and the clinicopathological and ultrasonographical characteristics of FVPTC has not been well studied. The aim of this study was to determine the significance of BRAF mutation in FVPTC . Patients The medical records of the 137 patients with >5 mm FVPTC s and known BRAF mutation status in the interested nodule were reviewed. BRAF mutation analysis was performed routinely and prospectively by Sanger sequencing. Clinicopathological and ultrasonographical characteristics were compared between BRAF mutation‐positive and BRAF mutation‐negative groups. Results BRAF mutation was detected in 35 (25·5%) patients. The BRAF mutation‐positive group was associated with smaller tumour size ( P = 0·022), extrathyroidal extension ( P = 0·001), multifocality ( P = 0·046) and higher ( III / IV ) TNM stages ( P = 0·005). In multivariable analysis, higher ( III / IV ) TNM stage was an independent predictive factor for BRAF mutation‐positive status (adjusted OR 2·966, 95% CI 1·321–6·663). In diagnosis of FVPTC , the presence of BRAF mutation was associated with malignant features on ultrasonography ( P < 0·001) and higher incidence of suspicious for malignancy or malignant diagnosis on the fine needle aspiration cytology ( P = 0·023). Sensitivity, specificity, positive predictive value, negative predictive value and accuracy of US for detecting BRAF mutation were 82·9%, 57·8%, 40·3%, 90·8% and 64·2%, respectively. Conclusions BRAF mutation in FVPTC is associated with unfavourable clinicopathological characteristics and malignant features on ultrasonography and may be a potential prognostic factor as it is in classical PTC .